Both in Pharmaceuticals
Scienture Holdings vs Aprea Therapeutics
Over the past year SCNX returned −83.3% and APRE returned −63.1%; their daily moves had a correlation of -0.00.
SCNX −83.3% APRE −63.1%Growth of $1, one year, split-adjusted
| Metric | SCNX | APRE |
|---|---|---|
| Price | $3.42 | $0.5052 |
| Market cap | $5.6M | $6.4M |
| Today | −0.87% | −1.90% |
| 1 month | −9.0% | −20.5% |
| 6 months | −65.0% | −39.4% |
| Year to date | −73.2% | −40.8% |
| 1 year | −80.7% | −63.9% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | 97.7% | — |
| Net margin | −821.3% | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1,226.8× |
| Net cash | -$1.4M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 933.5% | 95.9% |
| Short % of float | 0.3% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).